The value of COX-2 expression in the prognostic parameters of invasive ductal carcinoma of the breast

Medical Oncology

Volumn 28, Issue 3, 2011, Pages 703-708

  Barısık, Nagehan Ozdemir ^a   Keser, Sevinc Hallac ^a   Gul, Aylin Ege ^a   Sensu, Sibel ^a   Kandemir, Nilufer Onak ^a   Kucuk, Hasan Fehmi ^a   Gumus, Mahmut ^a   Karadayı, Nimet ^a  

^a Kartal Research and Education Hospital   (Turkey)

Author keywords

Breast carcinoma; Cyclooxygenase 2; Immunohistochemistry; Prognostic parameters

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; RECEPTOR ANTIBODY;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; CYTOPLASM; HISTOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; LYMPHOVASCULAR INVASION; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME;

EID: 80052500515     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9503-6     Document Type: Article

References (28)

1. C Denkert KJ Winzer BM Müler, et al. 2003 Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma Cancer 97 2978 2987 12784332 10.1002/cncr.11437 1:CAS:528:DC%2BD3sXlt1Shtbo%3D
2. G Perrone D Santini B Vincenzi, et al. 2005 COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features Histopathology 46 561 568 15842638 10.1111/j.1365-2559.2005.02132.x 1:STN:280:DC%2BD2M3gvVylug%3D%3D
3. DW Fadden DR Riggs BJ Jackson C Cunningham 2006 Additive effect of COX-1 and COX-2 inhibition on breast cancer in vitro Int J Oncol 29 1019 1023
4. KB Tan WP Yong TC Putti 2004 Cyclooxygenase-2 expression: a potential prognostic and predictive marker for high-grade ductal carcinoma in situ of breast Histopathology 44 24 28 14717665 10.1111/j.1365-2559.2004.01774.x
5. AS Soslow AJ Dannenberg D Rush, et al. 2000 COX-2 is expressed in human pulmonary, colonic, and mammary tumors Cancer 89 2637 2645 11135226 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B 1:CAS:528:DC%2BD3MXitFWisw%3D%3D
6. GK Yiu A Toker 2006 NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2 J Biol Chem 281 12210 12217 16505480 10.1074/jbc.M600184200 1:CAS:528:DC%2BD28XjvFKlu7o%3D
7. L Gallicchio MA McSorley CJ Newschaffer, et al. 2006 Nonsteroidal antiinflammatory drugs, cyclooxygenase polymorphisms, and risk of developing breast carcinoma among women with benign breast disease Cancer 106 1443 1452 16502408 10.1002/cncr.21763 1:CAS:528:DC%2BD28XjsFerurw%3D
8. N Barnes P Haywood P Flint WF Knox NJ Bundred 2006 Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence Br J Cancer 94 253 258 16421596 10.1038/sj.bjc.6602932 1:CAS:528:DC%2BD28XmvVynsA%3D%3D
9. LR Howe SH Chang KC Tolle, et al. 2005 HER-2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice Cancer Res 65 10113 10119 16267038 10.1158/0008-5472.CAN-05-1524 1:CAS:528:DC%2BD2MXhtFKkt7vO
10. LR Howe 2007 Cyclooxygenase/prostaglandin signaling and breast cancer Breast Cancer Res 9 210 17640394 10.1186/bcr1678
11. L Nakopoulou E Mylona I Papadaki A Kapranou I Giannopoulou 2005 Overexpression of cyclooxygenase-2 is associated with a favorable prognostic phenotype in breast carcinoma Pathobiology 72 241 249 16374068 10.1159/000089418 1:CAS:528:DC%2BD2MXhtlCks7vF
12. J Watson SY Chuah 1992 Techniques for primary culture of human breast cancer cells and measurement of their prostaglandin secretion Clin Sci 83 347 352 1327654 1:CAS:528:DyaK3sXovFw%3D
13. AM Fulton SZ Zhang YC Chong 1991 Role of the prostaglandin E2 receptor in mammary tumor metastasis Cancer Res 51 2047 2050 1849040 1:CAS:528: DyaK3MXit1KrsL0%3D
14. XH Liu DP Rose 1996 Differential expression and regulation of cyclooxygenase-1 in two human breast cancer cell lines Cancer Res 56 5125 5127 8912844 1:CAS:528:DyaK28XntFOnu78%3D
15. Rosai J. Rosai and Ackerman's surgical pathology. In: Rosai J, editor. Breast. Philadelphia: Mosby Year Book; 2004. p. 1763-876.
16. C Leo S Faber B Hentschel M Höckel LC Horn 2006 The status of cyclooxygenase-2 expression in ductal carcinoma in situ lesions and invasive breast cancer correlates to cyclooxygenase-2 expression in normal breast tissue Ann Diagn Pathol. 10 327 332 17126249 10.1016/j.anndiagpath.2006.03.002
17. AM Mohammad HA Abdel W Abdel AM Ahmed T Wael G Einman 2006 Expression of cyclooxygenase-2 and 12-lipoxygenase in human breast cancer and their relationship with HER-2/neu and hormonal receptors: impact on prognosis and therapy Indian J Cancer 43 163 168 17192687 10.4103/0019-509X.29421 1:STN:280:DC%2BD28jlsFGltg%3D%3D
18. MH Cho JH Yoon YJ Jaegal, et al. 2006 Expression of cyclooxygenase-2 in breast carcinogenesis and its relation to HER-2/neu and p53 protein expression in invasive ductal carcinoma Breast 15 390 398 16169726 10.1016/j.breast.2005. 06.011 1:STN:280:DC%2BD28zltFejsQ%3D%3D
19. VM Oliviera S Piato ALG Silva 2006 Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium Breast Cancer Res Treat 95 235 241 10.1007/s10549-005-9010-1
20. C Costa R Soares JS Reis-Filho D Leitao I Amendoiera FC Schmitt 2002 Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer J Clin Pathol 55 429 434 12037025 10.1136/jcp.55.6.429 1:STN:280:DC%2BD38zhs1Wrsw%3D%3D
21. A Ristimaki A Sivula M Lundin, et al. 2002 Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer Cancer Res 62 632 635 11830510 1:CAS:528:DC%2BD38Xht1KrtLg%3D
22. A Nassar A Radhakrishnan IA Cabrero G Cotsonis C Cohen 2007 COX-2 expression in invasive breast cancer correlation with prognostic parameters and outcome Appl Immunohistochem Mol Morphol 15 255 259 17721268 10.1097/01.pai.0000213130.63417.b3 1:CAS:528:DC%2BD2sXhtFGqu7bP
23. NJ Bundred NLP Barnes 2005 Potential use of COX-2-aromatase inhibitor combinations in breast cancer Br J Cancer 93 S10 S15 16100520 10.1038/sj.bjc.6602690 1:CAS:528:DC%2BD2MXns1Wrt7w%3D
24. CJ Witton SJK Hawe TJ Cooke JM Bartlett 2004 Cyclooxygenase.2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer Histopathology 45 47 54 15228443 10.1111/j.1365-2559.2004.01898.x 1:STN:280:DC%2BD2czislaqsw%3D%3D
25. FM Robertson SR Mallery VK Bergdall-Costell, et al. 2007 Cyclooxygenase-2 directly induces MCF-7 breast tumor cells to develop into exponentially growing, highly angiogenic and regionally invasive human ductal carcinoma xenografts Anticancer Res 27 719 727 17465194 1:CAS:528:DC%2BD2sXltVKmsbs%3D
26. G Roche-Nagle EM Connolly M Eng DJ Bouchier-Hayes JH Harmey 2004 Antimetastatic activity of a cyclooxygenase-2 inhibitor Br J Cancer 91 359 365 15213717 1:CAS:528:DC%2BD2cXls1eht78%3D
27. K Subbaramaiah L Norton W Gerald AJ Dannenberg 2001 Cyclooxygenase-2: a target for the prevention and treatment of breast cancer Endocr Relat Cancer 8 97 114 11397667 10.1677/erc.0.0080097
28. GP Boland IS Butt R Prasad WF Knox NJ Bundred 2004 COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ Br J Cancer 90 423 429 14735188 10.1038/sj.bjc.6601534 1:CAS:528:DC%2BD2cXksl2lsQ%3D%3D